baclofen has been researched along with Lung Injury, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, S | 1 |
| Merchant, ML | 1 |
| Ritzenthaler, JD | 1 |
| McLeish, KR | 1 |
| Lederer, ED | 1 |
| Torres-Gonzalez, E | 1 |
| Fraig, M | 1 |
| Barati, MT | 1 |
| Lentsch, AB | 1 |
| Roman, J | 1 |
| Klein, JB | 1 |
| Rane, MJ | 1 |
1 other study available for baclofen and Lung Injury, Acute
| Article | Year |
|---|---|
Baclofen, a GABABR agonist, ameliorates immune-complex mediated acute lung injury by modulating pro-inflammatory mediators.
Topics: Acute Lung Injury; Animals; Antigen-Antibody Complex; Apoptosis; Baclofen; Blotting, Western; Bronch | 2015 |